Skip to content

Ayuervedic Drug For Psoriasis.

"PHARMACOGNOSTICAL AND CLINICAL STUDY OF BHRINGARAJA(Eclipta alba Husk.)CHURNA IN EKA KUSTA W.S.R TO PSORIASIS" - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063713
Enrollment
30
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

CCRAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex between the age group of 20-60 years. 2. Patients presenting with the Eka kusta lakshanas ie Aswedhanam, Matsyasakalopamam 3. Disease chronicity less than 2 years

Exclusion criteria

Exclusion criteria: 1. Patients of age below 20 and above 60 years. 2. Pregnant and lactating women. 3. Patients suffering from chronic illness like HIV, HBSAg, CKD, and CAD. 4. Patient Disease chronicity more than 2 years.

Design outcomes

Primary

MeasureTime frame
Using of Bhringaraja Churna for 7 weeks (both oral and topical) ,reduction of itching ,scaling, and associated symptoms.Timepoint: 0 day, 15th day,30th day,45th day

Secondary

MeasureTime frame
To Improve the quality of lifeTimepoint: 0 day,15th day,30thday,45thday

Countries

India

Contacts

Public ContactDrSamarla Babu rao

DR Brkr Govt Ayurvedic Medical College.

baburaosamarla@gmail.com9885361326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026